Crescita Therapeutics (CTX) Stock Chart & Stock Price History C$0.49 +0.03 (+6.52%) As of 02:29 PM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsHeadlinesInsider TradesBuy This Stock Crescita Therapeutics Stock Price Performance The Crescita Therapeutics (CTX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 23.44%, with a year-to-date return of -15.52%. In the past month, the stock has increased 1.03%, reflecting recent market activity. As of the latest close, Crescita Therapeutics traded at C$0.46 with a market cap of C$8.47 million and volume of 16,500 shares. Five years ago, the stock traded at C$0.60, representing a 18.33% decrease over that period. At the time, it had a market cap of C$12.39 million and a volume of 3,000 shares. Receive CTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Crescita Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+4.26%1 Month Performance+1.03%3 Month Performance-5.77%Year-To-Date Performance-15.52%1 Year Performance-23.44%5 Year Performance-18.33% CTX Stock Chart for Thursday, August, 14, 2025 CTX Chart by TradingView Crescita Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/13/2025C$0.48C$0.46-4.17%C$0.47C$0.4616,500 shsC$8.47 million08/12/2025C$0.45C$0.48+6.67%C$0.51C$0.4620,050 shsC$8.84 million08/11/2025C$0.47C$0.45-4.26%C$0.48C$0.4586,038 shsC$8.28 million08/08/2025C$0.47C$0.47C$0.48C$0.474,500 shsC$8.65 million08/07/2025C$0.54C$0.47-12.96%C$0.53C$0.4766,651 shsC$8.65 million08/06/2025C$0.47C$0.54+14.89%C$0.55C$0.51121,727 shsC$9.94 million08/05/2025C$0.47C$0.47+1.08%C$0.47C$0.472,100 shsC$8.65 million08/04/2025C$0.47C$0.47C$0.47C$0.473,750 shsC$8.56 million08/01/2025C$0.47C$0.47C$0.47C$0.473,750 shsC$8.56 million07/31/2025C$0.47C$0.47C$0.47C$0.4712,000 shsC$8.56 million Get the Latest News and Ratings for CTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Crescita Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 07/30/2025C$0.47C$0.47-1.06%C$0.47C$0.4712,000 shsC$8.56 million07/29/2025C$0.47C$0.47C$0.47C$0.471,000 shsC$8.65 million07/28/2025C$0.47C$0.47C$0.47C$0.471,000 shsC$8.65 million07/25/2025C$0.47C$0.47C$0.47C$0.473,000 shsC$8.65 million07/24/2025C$0.47C$0.47C$0.47C$0.473,000 shsC$8.65 million07/22/2025C$0.47C$0.47C$0.47C$0.4718,594 shsC$8.65 million07/21/2025C$0.47C$0.47C$0.47C$0.4718,594 shsC$8.65 million07/18/2025C$0.47C$0.47+1.08%C$0.47C$0.4718,594 shsC$8.65 million07/17/2025C$0.49C$0.47-4.12%C$0.49C$0.4713,560 shsC$8.56 million07/16/2025C$0.49C$0.49C$0.49C$0.4828,550 shsC$8.93 million07/15/2025C$0.49C$0.49C$0.49C$0.4828,550 shsC$8.93 million07/14/2025C$0.49C$0.49C$0.49C$0.4828,550 shsC$8.93 million Related Companies LABS Stock Price Chart WLLW Stock Price Chart VM Stock Price Chart CWEB Stock Price Chart MPH Stock Price Chart ENTG Stock Price Chart AQS Stock Price Chart DHT.UN Stock Price Chart Receive CTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Crescita Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (TSE:CTX) was last updated on 8/14/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredBut this $20 American company could control the secretThe "Impossible" Chip That Runs on Pure Light Google's quantum computer shocked the world... but China DEMO...The Oxford Club | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Crescita Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Crescita Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access